Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.9018 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Zoe Diana Draelos und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acne Vulgaris, Clindamycin, Dermatologic Agents, Benzoyl Peroxide. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Draelos, Z. D., Ghannoum, M., Stein Gold, L., Harper, J. C., Baldwin, H., Guenin, E., & Tanghetti, E. A. (2025). Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9018
Vancouver
Draelos ZD, Ghannoum M, Stein Gold L, Harper JC, Baldwin H, Guenin E, et al. Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9018
BibTeX
@article{Draelos2025,
author = {Draelos, Zoe Diana and Ghannoum, Mahmoud and Stein Gold, Linda and Harper, Julie C and Baldwin, Hilary and Guenin, Eric and Tanghetti, Emil A},
title = {Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.9018}
}
EUVIMED